Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Frederick

Showing results (291-300 of 352) with videos related to

Pageof 36
Sort By:
Chemical Science|June 14, 2021
Single-ion magnetism in the extended solid-state: insights from X-ray absorption and emission spectroscopyMyron S Huzan, Manuel Fix, Matteo Aramini, et al.
Cancer Research|November 19, 2004
BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cellsThomas D Shellenberger, Mary Wang, Manu Gujrati, et al.
Journal of Ovarian Research|November 5, 2016
Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic diseaseAnna Strohl, Kristina Mori, Stacey Akers, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Targeted suppression of SPP1 inhibits tumor invasion and metastasis in NRF2 hyperactivated cisplatin resistant HNSCCMutsuki Kawabe, Sujuan Yang, Lorena Gomez Bolanos, et al.
Journal of Synchrotron Radiation|October 22, 2009
I18--the microfocus spectroscopy beamline at the Diamond Light SourceJ Frederick W Mosselmans, Paul D Quinn, Andrew J Dent, et al.
Biomaterials|August 18, 2018
Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticleAbhilash Samykutty, William E Grizzle, Benjamin L Fouts, et al.
Journal for Immunotherapy of Cancer|August 24, 2022
Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor responseKazi Mokim Ahmed, Ratna Veeramachaneni, Defeng Deng, et al.
Translational Oncology|June 20, 2026
Targeted inhibition of ATR kinase promotes antitumor immunity in HNSCC through enhanced STING activation and T cell functionFabio Hb da Costa, Mutsuki Kawabe, Tsung-You Tsai, et al.
Molecular Cancer Therapeutics|May 5, 2021
Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication StressAntje Lindemann, Ameeta A Patel, Lin Tang, et al.
Cell Reports|July 19, 2018
Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the EndometriumAlice H Hsu, Michelle A Lum, Kang-Sup Shim, et al.
Pageof 36

Showing results (291-300 of 352) with videos related to

Sort By:
Pageof 36
Chemical Science|June 14, 2021
Single-ion magnetism in the extended solid-state: insights from X-ray absorption and emission spectroscopyMyron S Huzan, Manuel Fix, Matteo Aramini, et al.
Cancer Research|November 19, 2004
BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cellsThomas D Shellenberger, Mary Wang, Manu Gujrati, et al.
Journal of Ovarian Research|November 5, 2016
Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic diseaseAnna Strohl, Kristina Mori, Stacey Akers, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Targeted suppression of SPP1 inhibits tumor invasion and metastasis in NRF2 hyperactivated cisplatin resistant HNSCCMutsuki Kawabe, Sujuan Yang, Lorena Gomez Bolanos, et al.
Journal of Synchrotron Radiation|October 22, 2009
I18--the microfocus spectroscopy beamline at the Diamond Light SourceJ Frederick W Mosselmans, Paul D Quinn, Andrew J Dent, et al.
Biomaterials|August 18, 2018
Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticleAbhilash Samykutty, William E Grizzle, Benjamin L Fouts, et al.
Journal for Immunotherapy of Cancer|August 24, 2022
Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor responseKazi Mokim Ahmed, Ratna Veeramachaneni, Defeng Deng, et al.
Translational Oncology|June 20, 2026
Targeted inhibition of ATR kinase promotes antitumor immunity in HNSCC through enhanced STING activation and T cell functionFabio Hb da Costa, Mutsuki Kawabe, Tsung-You Tsai, et al.
Molecular Cancer Therapeutics|May 5, 2021
Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication StressAntje Lindemann, Ameeta A Patel, Lin Tang, et al.
Cell Reports|July 19, 2018
Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the EndometriumAlice H Hsu, Michelle A Lum, Kang-Sup Shim, et al.
Pageof 36